Indicated for: moderate to severe pain
Route of administration: injectable
Substance: nalbuphine (opioid analgesic)
ATC: N02AF02 (Nervous system | Opioids | Morphinan derivatives)
Nalbuphine is an opioid analgesic used for the treatment of moderate to severe pain. It works by binding to opioid receptors in the central nervous system, reducing the perception of pain.
The medication is administered via intramuscular, subcutaneous, or intravenous injection, with the dose adjusted based on the intensity of pain and the patient's response. Common side effects include nausea, dizziness, drowsiness, and excessive sweating.
Nalbuphine is contraindicated in patients with hypersensitivity to the active substance or other opioids. It should also be used with caution in patients with respiratory or hepatic impairment.
This medication is an effective option for managing acute pain, frequently used in postoperative or trauma settings.